Two novel sulfonate phenol ligands—3,3′‐di‐ tert ‐butyl‐2′‐hydroxy‐5,5′,6,6′‐tetramethyl‐biphenyl‐2‐yl 4‐X‐benzenesulfonate (XCF 3 , L CF3 ‐H, and XOCH 3 , L OMe ‐H)—were prepared through the sulfonylation of 3,3′‐di‐ tert ‐butyl‐5,5′,6,6′‐tetramethylbiphenyl‐2,2′‐diol with the corresponding 4‐substituted benzenesulfonyl chloride (1 equiv.) in the presence of excess triethylamine. Magnesium (Mg) complexes supported by sulfonate phenoxide ligands were synthesized and characterized structurally. The reaction of Mg n Bu 2 with L‐H (2 equiv.) produces the four‐coordinated monomeric complexes ( L CF3 ) 2 Mg ( 1 ) and ( L OMe ) 2 Mg ( 2 ). Complexes 1 and 2 are efficient catalysts for the ring‐opening polymerization of ε‐caprolactone (ε‐CL) and trimethylene carbonate (TMC) in the presence of 9‐anthracenemethanol; complex 1 catalyzes the polymerization of ε‐CL and TMC in a controlled manner, yielding polymers with the expected molecular weights and narrow polydispersity indices (PDIs). In ε‐CL polymerization, the activity of complex 1 is greater than that of complex 2 , likely because of the greater Lewis acidity of Mg 2+ metal caused by the electron‐withdrawing substitute trifluoromethyl (CF 3 ) at the 4‐position of the benzenesulfonate group.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: